SNHG7 was first reported by Chaudhry in 2013 [31] and previous studies have demonstrated that SNHG7 is upregulated and plays an oncogenic role in cancers [32,33], including bladder cancer [34], breast cancer [35], colorectal cancer [36], and gastric cancer [37], and positively correlates with advanced clinicopathological features and prognosis. The gene discussed is SNHG7; the disease is cancer.